[BillyTheKing]

first of all, while Pfizer might just be producing at their factory in Belgium, that vaccine is produced in multiple factories in Germany by Biontech, most notably in Marburg (which is going to become Biontech's largest production site)

And secondly, 'just' producing the vaccine isn't the only bottleneck. Currently the biggest bottleneck seem to be two molecules that are produced earlier on in the production-process, and they're scarce.

So adding more production capacity upstream doesn't help if production capacity in factories downstream aren't scaled as well.

[hef19898]

Good point with upstream availability issues. I never really looked those up, simply because I have zero idea how vaccine manufacturing works. Until now, I only focused on the downstream side, everything after manufacturing. And I don't like what I see on that end, especially in Germany.

It is almost like the world at are is getting a crash course in supply chain management. One could have asked experts on that before, sure, but why bother when local politians need credits for their election campaigns, right?